Doug Brunk is a San Diego-based award-winning reporter who began covering health care in 1991. Before joining the company, he wrote for the health sciences division of Columbia University and was an associate editor at Contemporary Long Term Care magazine when it won a Jesse H. Neal Award. His work has been syndicated by the Los Angeles Times and he is the author of two books related to the University of Kentucky Wildcats men's basketball program. Doug has a master’s degree in magazine journalism from the S.I. Newhouse School of Public Communications at Syracuse University. Follow him on Twitter @dougbrunk.
News
Adequate disease control elusive for many patients on systemic AD therapies, study finds
“These findings suggest a need for alternative therapies and management strategies in AD treatment,” Dr. Jonathan I. Silverberg said.
News
Researchers making strides to better understand RA-associated interstitial lung disease
Two new studies aimed to develop more advanced risk scores using genetic factors or biomarkers, and a third looked to determine risk factors for...
News
Tape strips detect hidradenitis suppurativa biomarkers, novel study shows
The analysis is believed to be the first of its kind.
News
FDA mandates five changes to iPLEDGE program for isotretinoin
The changes follow a March 2023 meeting of the Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs...
News
Analysis supports link between psoriasis and obstructive sleep apnea
“This study further substantiates the association between psoriasis and OSA, reinforcing the importance of evaluation for OSA when clinically...
News
Autoimmune Skin Diseases Linked To Risk Of Adverse Pregnancy Outcomes
The three most common autoimmune skin diseases in the study cohort were vitiligo (30%), alopecia areata (30%), and cutaneous lupus erythematosus (...
News
Conditional recommendations rule in new SARD-associated interstitial lung disease guidelines
“Clinicians must retain the latitude to prescribe medications based on individual patient factors and preferences.”
News
Abatacept reduced rates of progression to RA, phase 2b trial finds
The study was conducted at 28 sites in the United Kingdom and 3 in The Netherlands.
News
Benralizumab proves noninferior to mepolizumab for rare vasculitis, EGPA
“I anticipate that the drug will be approved for use in EGPA, providing another option for treating this complicated multisystem eosinophilic-...
News
TNF inhibitors may be OK for treating RA-associated interstitial lung disease
Efficacy, safety findings for the use of TNF inhibitors vs. other biologic disease-modifying antirheumatic drugs in treating RA-ILD contrast with...
News
Vasculitis confers higher risk for adverse pregnancy outcomes
“This study should help inform our family planning conversations with our vasculitis patients,” Dr. Lindsay S. Lally said.
News
Sharps injuries are common among Mohs surgeons, survey finds
In the past year, 56.7% of respondents experienced at least one sharps injury.
News
Incipient ulceration may affect prognosis in primary melanoma
“Future editions of the AJCC staging system should consider acknowledging this interpretive challenge and provide guidance on how primary...
News
Pregnancies with low anti-SSA/Ro autoantibody levels: Forgo fetal heart rhythm monitoring?
The ongoing prospective multicenter trial is the largest of its kind.
News
AAD updates guidelines for managing AD with phototherapy and systemic therapies
The work group recommended the inclusion of active comparator arms in randomized, controlled trials as new systemic therapies continue to be...